EQUILIBRE
Live / Registered — Registered (as of 30 May 2023)
What this means for you
Registered since 30 May 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90581710
- Registration number
- 7069162
- Mark type
- Stylized text
- Filed
- 16 Mar 2021
- Published for opposition
- 19 Jul 2022
- Registered
- 30 May 2023
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, pharmaceutical preparations and pharmaceutical agents for treatment of neurodegenerative diseases, acute inflammatory conditions, and not for use in connection with the treatment of urological or urinary tract diseases and disorders
Owner
- EQUILIBRE BIOPHARMACEUTICALS B.V., Amsterdam, NL
- EQUILIBRE BIOPHARMACEUTICALS B.V., Amsterdam, NL
- EQUILIBRE BIOPHARMACEUTICALS CORP., AMSTERDAM, NL
- Equilibre Biopharmaceuticals Corp., New York, NY, US
Prosecution history
- 30 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 25 Apr 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Apr 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Mar 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Mar 2023 — USE AMENDMENT FILED
- 17 Mar 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Mar 2023 — TEAS STATEMENT OF USE RECEIVED
- 14 Sept 2022 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 13 Sept 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Jul 2022 — PUBLISHED FOR OPPOSITION
- 29 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jun 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER